The global direct-to-consumer genetic testing market size was US$ 1,338.6 million in 2021. The global direct-to-consumer genetic testing market size is forecast to reach US$ 5,573.5 million by 2030, growing at a compound annual growth rate (CAGR) of 17.6% during the forecast period from 2022 to 2030.

Direct-to-consumer (DTC) genetic testing is a marketing strategy that uses television, print media, and the Internet to advertise genetic tests to customers. Furthermore, the tests can be purchased online or in stores, and this marketing takes place without the involvement of a health care physician. Customers send their DNA samples directly to the company, and the results are available in the form of electronic reports on their website. Direct-to-consumer genetic testing provides convenience for people who live in remote areas because they don't have to deal with insurance companies and healthcare providers. 

Factors Influencing Market Growth

• Global market drivers include the rising acceptance of DTC genetic testing for its abilities for early disease diagnosis and recognition of genetic mutation preceding its manifestation.
• The higher prices of (DTC) genetic testing and flaws in the testing kits are rising the risk associated with false interpretations and may slow down the market growth.
• The growing advancement in technology due to the rising R&D activities has allowed researchers and healthcare specialists to interpret the information in human genetic material and derive useful understandings to aid in treating various diseases. It has resulted in the development of many direct-to-consumer genetic tests. Thus, this factor is forecast to create lucrative opportunities for the global market.

Impact Analysis of COVID-19

COVID-19 pandemic positively impacted the direct-to-consumer genetic testing market. During the COVID-19 pandemic, technological advancements have created new business opportunities in direct-to-consumer genetic testing. The rapid development of direct-to-consumer genetic testing was due to the growing number of chronic diseases and the introduction of personalized testing kits for niche therapeutic areas. Such transformation and evolution in services have boosted the demand for such kits. Also, the availability of these kits on online platforms has boosted the global market growth.

Regional Insights

North America accounted for the largest market share in 2021. As a result of the changing perspective of consumers towards genetic testing and rising expenditure. The increasing amount of disposable income allows consumers to spend more on direct-to-consumer genetic testing, such as ancestral and nutrigenomics tests and continuous projects are forecast to drive the market growth in the region.  

Leading Competitors

The leading prominent companies profiled in the global direct-to-consumer genetic testing market are:

• Easy DNA
• Ancestry
• Color Genomics
• Full Genome Corporation
• Helix OpCo LLC
• Identigene
• Karmagenes
• FamilyTreeDNA
• Mapmygenome
• Pathway genomics
• Genesis Healthcare
• Other Prominent Players

Scope of the Report

The global direct-to-consumer genetic testing market segmentation focuses on Technology, Distribution Channel, Product Type, and Region.

Segmentation based on Technology

• Single Nucleotide Polymorphism
• Targeted Analysis
• Whole Genome Sequencing

Segmentation based on Distribution Channel

• Online Channel
• over-the-counter (OTC) Channel

Segmentation based on Product Type

• Ancestry
• Health and Wellness
• Entertainment

Segmentation based on Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America